Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient

J Neurol. 2013 Jun;260(6):1675-7. doi: 10.1007/s00415-013-6933-z. Epub 2013 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Age of Onset
  • Brain / pathology
  • Child
  • Cyclophosphamide / therapeutic use
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Magnetic Resonance Imaging
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Plasma Exchange
  • Propylene Glycols / adverse effects*
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*
  • Young Adult

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Cyclophosphamide
  • Fingolimod Hydrochloride
  • Sphingosine